Arch Therapeutics (ARTH)
(Delayed Data from OTC)
$0.52 USD
0.00 (0.00%)
Updated Aug 28, 2024 02:42 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Arch Therapeutics, Inc falls in the month of September.
All items in Millions except EPS data.
9/30/23 | 9/30/22 | 9/30/21 | 9/30/20 | 9/30/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | 0 | 0 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 5 | 6 | 6 | 5 | 6 |
Income After Depreciation & Amortization | -5 | -6 | -6 | -5 | -6 |
Non-Operating Income | 1 | 1 | 0 | 1 | 2 |
Interest Expense | 3 | 1 | 0 | 0 | 0 |
Pretax Income | -7 | -5 | -6 | -5 | -5 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -7 | -5 | -6 | -5 | -5 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -7 | -5 | -6 | -5 | -5 |
Depreciation Footnote | 9/30/23 | 9/30/22 | 9/30/21 | 9/30/20 | 9/30/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -5 | -6 | -6 | -5 | -6 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 0 | 0 | 0 |
Income After Depreciation & Amortization | -5 | -6 | -6 | -5 | -6 |
Earnings Per Share Data | 9/30/23 | 9/30/22 | 9/30/21 | 9/30/20 | 9/30/19 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | -2.27 | -4.00 | -6.00 | -4.00 | -6.00 |
Fiscal Year end for Arch Therapeutics, Inc falls in the month of September.
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 0.03 | 0.03 | 0.05 | 0.04 | 0.01 |
Cost Of Goods | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
Gross Profit | 0.01 | 0.01 | 0.02 | 0.02 | -0.01 |
SG&A, R&D, and Dept/Amort Expenses | 1.04 | 0.88 | 1.52 | 1.35 | 1.01 |
Income After SG&A, R&D, and Dept/Amort Expenses | -1.03 | -0.87 | -1.50 | -1.33 | -1.02 |
Non-Operating Income | -3.96 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 0.67 | 0.59 | 1.19 | 1.13 | 0.81 |
Pretax Income | -5.65 | -1.47 | -2.68 | -2.46 | -1.82 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -5.65 | -1.47 | -2.68 | -2.46 | -1.82 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -5.65 | -1.47 | -2.68 | -2.46 | -1.82 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 4.44 | 4.50 | 4.71 | NA | 1.28 |
Diluted EPS Before Non-Recurring Items | -1.44 | -0.33 | -0.57 | NA | -1.42 |
Diluted Net EPS (GAAP) | -1.44 | -0.33 | -0.57 | 1.30 | -1.42 |